Insulin Pump Market Share, Size, Growth, Statistics & Industry Report, 2020-2027
Insulin Pump Market Size, Share & Analysis Report by Treatment (Type 1 Diabetes and Type 2 Diabetes), By Type (Traditional Insulin Pumps, Patch Insulin Pumps and Hybrid Closed-Loop Pumps), By End User (Hospitals, Clinics, Home Care Labs, Laboratories, and Others) and By Region – Global Opportunities & Forecast, 2020-2027
Published Date: Jun - 2021 | Report Format: Excel/PPT | Report Code: UP1902-001001
Introduction of the Insulin Pump Market Report
An insulin pump is a medical device used for delivering small doses of insulin for the treatment of diabetes. Pumps use short-acting and rapid acting insulin in response to the instructions given by the pump wearer. Basically, it is a small device which is composed of certain components like, tubing, pumps, infusion set, angled set and straight set, which helps in the management of diabetes. New development in the insulin pump technology has pushed the global insulin pump market ahead.
To have an edge over the competition by knowing the market dynamics and current trends of “Insulin Pump Market”, request for Sample Report here
Market Dynamic
Key Drivers and Emerging Trends
Rise in the prevalence of chronic disease like type I and type II diabetes is a factor that has contributed majorly for the adoption of insulin pumps market across the globe. For instance, according to “Diabetes Research and Clinical Practice”, the prevalence of diabetes is expected to reach 10.2% from by the end of 2030 from 9.3% in 2019, which is anticipated to boost the growth of the global insulin pump market. According to PubMed, 465 million adults were living with diabetes in 2019 and the number is expected to reach to more than 700 million by the end of 2045, thereby creating robust growth in the insulin pumps market. Advancement of home infusion therapy and artificial pancreas is further driving the growth of this market to a certain extent. Moreover, skilled and consumer information programs provided by insulin infusion pump manufacturers are encouraging adoption of insulin delivering devices and ultimately driving the growth of this market. For instance, medical education program on diabetes by Medtronic has helped the medical device industry and diabetes patients in managing special considerations in therapy.
In addition, the increasing number of FDA approval of insulin pumping devices has changed the patient and industrial behaviour in a positive aspect and has forced the growth of the global insulin pump market. For instance, in 2020 Medtronic got approval from FDA of the MiniMed 770G hybrid insulin pump.
Restraint in the Insulin Pump Market
However, high cost associated of the device and maintenance is the major factor that is anticipated to hamper the growth of the global insulin pump market.
Do you want to know more about the Research process and detailed Methodology, Request Research Methodology of this report
Type – Segment Analysis
Based on the type, patch insulin pumps is expected to grow at a higher CAGR in the global insulin pump market over the forecast period. Patch pumps are very small in size and easily be attached to the surface of skin of the patient. Furthermore, incorporation of calculators helps govern the exact dosage of insulin needed by patients and avoid overdose. These factors are likely to boost the market growth during the forecast period.
End User – Segment Analysis
Based on the end user, hospitals are expected to dominate the global insulin pump market over the forecast period. This is due to the availability of the skilled labour professionals coupled with the increase in number of hospitals, which has contributed for the dominance of the segment.
In case, any of your pain points areas are not covered in the current scope of this report, Request for Free Customization here
Regional – Segment Analysis:
Based on the region, North America region is expected to dominate the global insulin pump market over the forecast period. Reason behind the regional domination is the high rate of incidence of diabetes in Americas. According to NCBI, the annual death rate of diabetes is expected to reach 54% by the end of 2030 from 2015, which is acting as a pushing factor for the regional insulin pump market. In addition, the presence of key players in the region has also augmented the demand for insulin pumps. For instance, Medtronic, Abbott, F. Hoffmann-La Roche Ltd, etc. have strong presence in the region which is another factor driving the North America Insulin Pump Market.
Top Market Players
Various notable players operating in the market, include, Medtronic, Abbott, F. Hoffmann-La Roche Ltd, Insulet Corporation, Tandem Diabetes Care, Inc., Insulet Corporation, Ypsomed, SOOIL Developments Co., Ltd, delfu-medical.com, Medtrum Technologies, among others.
Key Developments:
-
- In 2020, Insulte Corporation announced the expansion of the product offering, omnipod DASH for insulin management and thereby expanding its product portfolio.
Segments covered in the Report:
The global insulin pump market has been segmented based on treatment, type, end user and regions. Based on treatment, the market is segmented into type 1 diabetes and type 2 diabetes. Based on type, the market is segmented into traditional insulin pumps, patch insulin pumps and hybrid closed-loop pumps. Based on end user the market is segmented into hospitals, clinics, home care labs, laboratories, and others.
For detailed scope of the “Insulin Pump Market” report request a Sample Copy of the report
Key questions answered in this research report:
-
- At what pace is global insulin pump market growing? What will be the growth trend in the future?
- What are the key drivers and restraints in insulin pump market? What will be the impact of drivers and restraints in the future?
- What are the regional revenues and forecast breakdowns? Which are the major regional revenue pockets for growth in the global insulin pump market?
- Which treatment generated maximum revenues in 2019 and identify the most promising treatment during the forecast period?
- What are the various type areas of global insulin pump market and how they are poised to grow?
- What companies are the major participants in this market and their business strategies, how does the competitive landscape look like?
Report Coverage |
Details |
Market Base Year |
2019 |
Market Forecast Period |
2020-2027 |
Market Revenues Currency |
USD Million |
Base Year & Forecast Units |
Revenues (USD Million) |
Market Segment | By Treatment, By Type, By End User, By Region |
Regional Coverage | Asia Pacific, Europe, North America, and RoW |
Companies Profiled | Medtronic, Abbott, F. Hoffmann-La Roche Ltd, Insulet Corporation, Tandem Diabetes Care, Inc., Insulet Corporation, Ypsomed, SOOIL Developments Co., Ltd, delfu-medical.com, Medtrum Technologies, among others; a total of 10 companies covered. |
25% Free Customization Available | We will customize this report up to 25% as a free customization to address our client’s specific requirements |
Market Segmentation
Global Insulin Pump Market by Treatment
-
- Type 1 Diabetes
- Type 2 Diabetes
Global Insulin Pump Market by Type
-
- Traditional Insulin Pumps
- Patch Insulin Pumps
- Hybrid Closed-Loop Pumps
Global Insulin Pump Market by End User
-
- Hospitals
- Clinics
- Home Care Labs
- Laboratories
- Others
Global Insulin Pump Market by Region
-
- North America Insulin Pump Market (Option 1: As a part of the free 25% customization)
- North America Insulin Pump Market by Treatment
- North America Insulin Pump Market by Type
- North America Insulin Pump Market by End User
- US Insulin Pump Market All-Up
- Canada Insulin Pump Market All-Up
- Europe Insulin Pump Market (Option 2: As a part of the free 25% customization)
- Europe Insulin Pump Market by Treatment
- Europe Insulin Pump Market by Type
- Europe Insulin Pump Market by End User
- UK Insulin Pump Market All-Up
- Germany Insulin Pump Market All-Up
- France Insulin Pump Market All-Up
- Spain Insulin Pump Market All-Up
- Rest of Europe Insulin Pump Market All-Up
- Asia-Pacific Insulin Pump Market (Option 3: As a part of the free 25% customization)
- Asia-Pacific Insulin Pump Market by Treatment
- Asia-Pacific Insulin Pump Market by Type
- Asia-Pacific Insulin Pump Market by End User
- China Insulin Pump Market All-Up
- India Insulin Pump Market All-Up
- Japan Insulin Pump Market All-Up
- Rest of APAC Insulin Pump Market All-Up
- RoW Insulin Pump Market (Option 4: As a part of the free 25% customization)
- RoW Insulin Pump Market by Treatment
- RoW Insulin Pump Market by Type
- RoW Insulin Pump Market by End User
- Brazil Insulin Pump Market All-Up
- South Africa Insulin Pump Market All-Up
- Saudi Arabia Insulin Pump Market All-Up
- UAE Insulin Pump Market All-Up
- Rest of world (remaining countries of the LAMEA region) Insulin Pump Market All-Up
- North America Insulin Pump Market (Option 1: As a part of the free 25% customization)
Major Players Operating in the Insulin Pump (Option 5: As a part of the Free 25% Customization – Profiles of 5 Additional Companies of your Choice)
-
- Medtronic
- Abbott
- Hoffmann-La Roche Ltd.
- Insulet Corporation
- Tandem Diabetes Care, Inc
- Insulet Corporation
- Ypsomed
- SOOIL Developments Co., Ltd.
- delfu-medical.com
- Medtrum Technologies
Licensing Options
Single-User License:
The report is used by the purchaser (One Individual) only
Multi-User License:Report is shared with maximum 5 users (employees) including the purchaser of the purchasing corporation only
Corporate License:
Report is shared with unlimited user (employees) of the purchasing corporation only
The report is used by the purchaser (One Individual) only
Multi-User License:Report is shared with maximum 5 users (employees) including the purchaser of the purchasing corporation only
Corporate License:
Report is shared with unlimited user (employees) of the purchasing corporation only
Insulin Pump Market Share, Size, Growth, Statistics & Industry Report, 2020-2027
$ 4,499.00 – $ 6,649.00